Atabecestat
Atabecestat (JNJ-54861911) is a potent, brain-penetrant, and orally active β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor that achieves robust and high CSF Aβ reduction, is well-tolerated, and displays sustained pharmacokinetic (PK) and pharmacodynamic (PD) characteristics. Atabecestat (JNJ-54861911) has the potential for Alzheimer's Disease treatment.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
367.4
Molecular Formula
C18H14FN5OS
Notes
Research use only, not for human use.
Receptor
BACE
CAS Number
1200493-78-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1130910-01 0.02 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Proteasome component PRE6 (PRE6)
Ask
View Details MBS1130910-02 0.1 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Proteasome component PRE6 (PRE6)
Ask
View Details MBS1130910-03 0.02 mg (Yeast)
Recombinant Saccharomyces cerevisiae Proteasome component PRE6 (PRE6)
Ask
View Details MBS1130910-04 0.1 mg (Yeast)
Recombinant Saccharomyces cerevisiae Proteasome component PRE6 (PRE6)
Ask
View Details MBS1130910-05 0.02 mg (Baculovirus)
Recombinant Saccharomyces cerevisiae Proteasome component PRE6 (PRE6)
Ask
View Details 
MBS1130910-06 0.02 mg (Mammalian-Cell)
Recombinant Saccharomyces cerevisiae Proteasome component PRE6 (PRE6)
Ask
View Details